GI Dynamics, a medical device company pioneering the development of new approaches to treating metabolic disorders, today announced that new data regarding EndoBarrier(TM), its novel, noninvasive device currently in clinical trials to treat obesity and type 2 diabetes, will be presented at the International Federation for Surgery of Obesity and Metabolic Disorders (IFSO) 13th World Congress in …
More: continued here